Cargando…
High-Intensity Chemotherapy is Associated with Better Prognosis in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma: A 10-Year Single-Center Retrospective Cohort Study
BACKGROUND: Patients <60 years old with high-risk diffuse large B-cell lymphoma (DLBCL) receiving standard RCHOP(E) treatment display high relapse rates. Here, we compared this standard regimen to a high-intensity regimen in terms of recurrence and long-term survival. MATERIAL/METHODS: Newly diag...
Autores principales: | Ma, Xiaorong, Xu, Yan, Zhang, Wanggang, Wang, Jin, Cao, Xingmei, Chen, Yinxia, He, Aili, Liu, Jie, Wang, Jianli, Zhao, Wanhong, Yang, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913830/ https://www.ncbi.nlm.nih.gov/pubmed/27232105 http://dx.doi.org/10.12659/MSM.895383 |
Ejemplares similares
-
Extended Course and Increased Dose of Initial Chemotherapy for Extranodal Nasal Type Natural Killer/T (NK/T)-Cell Lymphoma in Patients <60 Years Old: A Single-Center Retrospective Cohort Study
por: Xu, Yan, et al.
Publicado: (2016) -
Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center, retrospective cohort study
por: Ma, Xiaorong, et al.
Publicado: (2016) -
Long non-coding RNA RPPH1 promotes the proliferation, invasion and migration of human acute myeloid leukemia cells through down-regulating miR-330-5p expression
por: Lei, Bo, et al.
Publicado: (2019) -
MLAA-34 knockdown shows enhanced antitumor activity via JAK2/STAT3 signaling pathway in acute monocytic leukemia
por: Lei, Bo, et al.
Publicado: (2020) -
High-intensity chemotherapy improved the prognosis of patients with high-grade B-cell lymphoma
por: Chen, Yanfang, et al.
Publicado: (2022)